Clinical trial
Safety and Efficacy of Etanercept in Patients With Psoriasis
NCT02258282 is registered in ClinicalTrials.gov with Chengdu PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Etanercept in Patients With Psoriasis
- Lead sponsor
- Chengdu PLA General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2014
- Completion date
- December 31, 2022
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.